Background-Previous investigations provide evidence that an enzyme related to the phagocyte NADPH oxidase produces superoxide in the blood vessel wall. These data, however, are confounded by observations that both NADPH and NADH serve as substrates for superoxide production in vascular cells. To clarify this issue, we compared the superoxidegenerating capabilities of vascular smooth muscle cells (VSMCs) derived from wild-type (p47phox ϩ/ϩ ; phagocyte oxidase) mice with those from mice that lack p47phox (p47phox Ϫ/Ϫ ; "knockout"), an essential component of the phagocyte NADPH oxidase. Methods and Results-VSMCs were derived from aortic explants harvested from p47phox ϩ/ϩ or p47phox Ϫ/Ϫ mice.
I n the cardiovascular system, multiple functions for reactive oxygen species (ROS) are becoming apparent, including signal transduction in vascular smooth muscle cells (VSMCs) 1 and blood pressure homeostasis. 2 A primary source of ROS, superoxide anion can be converted into hydrogen peroxide, which may be detrimental to cardiovascular performance through its ability to promote VSMC proliferation. 3 Therefore, local vascular levels of superoxide anions may determine whether physiological or pathological circumstances prevail, which suggests that regulation of the production of these mediators may provide a novel therapeutic approach to intervention in cardiovascular disease.
Pharmacological or genetic control of ROS release in cardiovascular tissue necessitates the identification of the enzyme(s) responsible for their production. Several investigations have suggested that a variety of enzymes, including a phagocyte-like NADPH oxidase, function in the blood vessel wall. The phagocytic enzyme is composed of 5 essential components, including 2 that are membrane-bound: p22phox (phagocyte oxidase) and gp91phox, and 3 that are located in the cytosol: p47phox, p67phox, and Rac1 (guinea pig) or Rac2 (human). 4 NADPH-dependent superoxide production detected in cell-free assays of nonstimulated rabbit aorta preparations was inhibited by diphenyleneiodonium (DPI), an inhibitor of NADPH oxidase and other flavoenzymes, [5] [6] [7] whereas NADH yielded less superoxide when used as a substrate. 8 In contrast, NADH-dependent superoxide generation exhibited by human umbilical vein endothelial cell 9 or rabbit aortic adventitial fibroblast preparations 10 was greater than the activity observed when NADPH was used as a substrate. In both studies, basal NADPH-dependent superoxide production was preferentially inhibited by DPI compared with basal NADH-dependent activity. In contrast, angiotensin II (Ang II)-stimulated superoxide generation in adventitial fibroblasts was DPI-sensitive when either substrate was provided. 10 Both immunochemical 10 -14 and genetic 9, [11] [12] [13] 15 evidence suggest that phagocyte NADPH oxidase (phox) components are present and functional in blood vessels 10, 11, 13, 14 and vascular cells (endothelial cells, smooth muscle cells, and fibroblasts), 9 -13,15 although the substrate preferences and pharmacological sensitivities of the putative oxidases involving these components were not always explored. Gorlach et al 11 recently demonstrated that gp91phox is involved in ROS production by endothelial cells by comparing aortic vessel segments derived from wild-type and gp91phox-deficient mice, although NADPH-dependent superoxide release in these whole tissues did not involve gp91phox. Together, the results of these investigations imply that several superoxide-producing enzymes function in the blood vessel wall, including more than one 1 enzyme that preferentially uses NADPH or NADH under basal conditions, and agonist-stimulated oxidases that are DPI-sensitive and use either substrate as a source of electrons.
In light of recent data that indicate the presence of p47phox in VSMCs and suggest a role for p47phox in VSMC mitogenesis, 13 the present study was undertaken to address directly whether an oxidase requiring the p47phox component participates in agonist-stimulated superoxide production in VSMCs. By comparing the abilities of phorbol myristate acetate (PMA), Ang II, and platelet-derived growth factor (PDGF) to stimulate superoxide production in VSMCs derived from p47phox ϩ/ϩ and p47phox Ϫ/Ϫ mice, our studies indicate that p47phox is an essential component of a superoxide-generating system in these cells.
Methods

Derivation of Murine VSMCs
The p47phox Ϫ/Ϫ mouse, which was created as a murine model for chronic granulomatous disease by targeted disruption of the p47phox gene, has been described previously. 16 For each set of experiments, aortas from 3 adult (12 to 16 weeks old) female C57BL/6 p47phox ϩ/ϩ or C57BL/6 p47phox Ϫ/Ϫ mice were harvested 2 to 3 minutes after their death by cervical dislocation. The vessels were transferred into culture medium (SmGM-2; includes 5% FBS; Clonetics). The vessels were stripped of connective tissue, cut into rings (3 to 5 mm long), and placed onto sterile plastic 24-well or 6-well tissue culture plates. After Ϸ21 days, the cells were harvested for experimentation.
Experimental Protocols
VSMCs derived from aortic explants of p47phox ϩ/ϩ or p47phox Ϫ/Ϫ mice were collected and distributed as follows: (1) for phase-contrast microscopy or indirect immunofluorescence staining to detect a VSMC antigenic marker, ␣-smooth muscle actin, 17 or p47phox; (2) for chemiluminescence measurement of superoxide production; or (3) for serial passage and measurement of superoxide production as follows: 10% of the population of cells of each genotype was seeded into T-25-cm 2 plastic tissue-culture-treated flasks (passage 1, P1; Nalge NUNC International). On reaching 90% to 100% confluence, the VSMCs were trypsinized and distributed for chemiluminescence assays or propagation as for P1 (ie, 10% of the P1 cells was distributed to a T-25-cm 2 flask; P2). Therefore, the relative expansion of cultures was the product of the dilution factor for each passage (10) multiplied by the relative density of cultures at each passage.
Phase-Contrast and Indirect Immunofluorescence Microscopy
Before harvest, cells derived from p47phox ϩ/ϩ or p47phox Ϫ/Ϫ explants were observed by phase-contrast microscopy and photographed. For this purpose, the cells were rinsed twice with 1ϫ PBS and left submerged in this medium for microscopic viewing (Zeiss) and photography.
VSMCs derived from p47phox ϩ/ϩ and p47phox Ϫ/Ϫ mice were harvested for immunofluorescence detection of ␣-smooth muscle actin and p47phox. For the detection of ␣-smooth muscle actin, a monoclonal anti-␣-smooth muscle actin antibody (Clone 1A4; Sigma) or the isotype control, mouse IgG2a (Sigma) were used. These primary antibodies were detected with a Texas redconjugated sheep anti-mouse antibody (Jackson ImmunoResearch). Detection of p47phox was performed with specific goat polyclonal anti-human p47phox serum as described. 18
Measurement of ROS
To measure superoxide generated by VSMCs derived from p47phox ϩ/ϩ and p47phox Ϫ/Ϫ mice, a mixture of a superoxide anionspecific chemiluminescence indicator reagent (Diogenes; National Diagnostics; 50% of total reaction volume) containing dimethylsulfoxide (vehicle for PMA), human Ang II (10 nmol/L; Sigma), human PDGF-BB (5 ng/mL; Sigma), or PMA (2 g/mL; Sigma) was added to adherent VSMCs previously cultured (1ϫ10 4 cells/well, 37°C overnight) in sterile microtiter chemiluminescence plates (Dynex Technologies). The cells were cultured in culture medium ( Figure 2 and Table 1 ) or in medium consisting of SmBM (Clonetics) PMA-stimulated (2 g/mL) superoxide production occurred only in p47phox ϩ/ϩ VSMCs but declined significantly with cell passage and time (knockout, ko; wild-type, wt). At P1, * indicates that mean superoxide production yielded by wt/pma was significantly greater than other cultures at P1 (PϽ0.05; paired t tests). Mean superoxide produced by P2 wt/pma was significantly greater than P3 wt/pma. Data were obtained from triplicate measurements and represent 3 independent experiments.
containing 0.5% FBS, 1% penicillin-streptomycin, and 1% glutamine ( Figure 5 and Table 2 ). The dose of each physiological agonist used was determined on the basis of earlier investigations. 10, 19, 20 Total superoxide dismutase (SOD)-inhibitable superoxide generation was measured in a luminometer (Labsystems Luminoskan; 0.5-second readings obtained at 1-minute intervals over 40 minutes).
Retroviral Transduction of Murine VSMCs
VSMCs derived from p47phox ϩ/ϩ or p47phox Ϫ/Ϫ mice were seeded into T-75-cm 2 flasks (Nalge NUNC International). After reaching 75% confluence, cells were transduced for 3 consecutive days with amphotropic packaged MFGS retrovirus by methods described elsewhere. 21 Briefly, the cells were covered with medium containing enhanced green fluorescent protein (EGFP; control) or human p47phox cDNA 21 in X-VIVO 10 (BioWhittaker) medium (diluted 1:1 with culture medium) including protamine (6 g/mL). These cultures were centrifuged at 525g for 20 minutes at 32°C and incubated at 37°C for 8 hours, after which time the viral supernatants were replaced with fresh culture medium. After overnight incubation of the cells at 37°C, this spin-transduction protocol was repeated for 2 consecutive days. These transduced cells were then analyzed for p47phox production and superoxide production 4 days after the initial transduction. Indirect immunofluorescence detection of ␣-smooth muscle actin (p47phox ϩ/ϩ , E, and p47phox Ϫ/Ϫ , F), an antigenic marker of VSMCs 17 and an indicator of VSMC phenotypic status, 22 revealed no differences in the content (Ͼ95%) of positively stained cells between cultures. These results confirmed the identity of these cultures and indicated that a deficiency of p47phox did not produce discernible morphological or phenotypic differences between cells.
Results
Phase-Contrast Microscopy and Indirect Immunofluorescence Staining of ␣-Smooth Muscle Actin
Superoxide Production by Murine VSMCs
To directly test whether p47phox is involved in superoxide release by VSMCs, we compared the abilities of cultures derived from p47phox ϩ/ϩ and p47phox Ϫ/Ϫ aortic explants to generate superoxide. We considered the possibility that these cultures contained tissue-derived macrophages, which could represent a source of superoxide but would fail to divide in culture. To test this possibility, we compared superoxide production between culture passages against the extent of cell culture expansion between passages ( Figure 2 and Table 1 ). To stimulate the cells, we used PMA (2 g/mL), a potent nonphysiological agonist used to activate NADPH oxidase. 4 Figure 2 shows that basal production of superoxide in P1 p47phox ϩ/ϩ cultures was approximately equivalent to that produced by P1 p47phox Ϫ/Ϫ cells. This low level of superoxide release yielded by p47phox Ϫ/Ϫ cells was not inhibited by DPI (8 mol/L; not shown). Therefore, nonstimulated superoxide release detected in these cultures could originate from nonflavoenzymatic sources, such as cyclooxygenases. PMA stimulated significant superoxide production by P1 p47phox ϩ/ϩ cells, which occurred within a 40-minute assay, Data were obtained from triplicate measurements and represent 3 independent experiments for each passage number.
*Measured as described in Methods. †Equivalent to product of dilution factor (10) ϫ relative culture density between each passage. ‡Relative to previous passage.
but not by P1 p47phox Ϫ/Ϫ cells ( Figure 2 ). With each passage, superoxide production declined, but not to the extent predicted for nondividing cells when considering the extent of culture expansion ( Figure 2 and Table 1 ). These observations suggest that superoxide production in p47phox ϩ/ϩ cultures was derived from VSMCs, but not from tissue macrophages. In addition, inspections of PMA-stimulated p47phox ϩ/ϩ culture stained with nitro blue tetrazolium revealed no contaminating phagocytic cells with a high superoxide output (not shown). We suspected that reductions in superoxide release were related to reduced expression of NADPH oxidase components during culture, analogous to that previously observed in monocyte-derived macrophages maintained in vitro. 23 These observations appear to be inconsistent with those in a previous study, which indicated that PMA fails to stimulate ROS release from human VSMCs or endothelium-denuded aortic segments (rat and mouse) 11 ; other authors, however, reported that PMA stimulates ROS production in VSMCs. 24 Differences in PMA doses or sensitivities of the superoxidedetecting systems may account for these discrepancies.
Endogenous p47phox was selectively detected in P1 p47phox ϩ/ϩ VSMCs ( Figure 3A ; corresponding phasecontrast image in Figure 3C ), indicating that the p47phox deficiency in p47phox Ϫ/Ϫ VSMCs ( Figure 3B ; corresponding phase-contrast image in Figure 3D ) may account for their inability to produce superoxide after PMA stimulation.
Superoxide Production in p47phox ؊/؊ VSMCs Transduced With Recombinant p47phox
Together, the results presented in Figures 2 and 3 suggest that the ability of p47phox ϩ/ϩ VSMCs to produce superoxide is related to selective expression of p47phox in these cells. To test this hypothesis, P1, 3-week-old p47phox ϩ/ϩ and p47phox Ϫ/Ϫ VSMC cultures were retrovirally transduced with human recombinant p47phox, and superoxide production was measured in response to stimulation by Ang II or PDGF-BB. These agonists are relevant because they induce reactive oxidant release by vascular cells 10, 13, 15, 19, 20, 25, 26 and seem to play roles in the pathogeneses of hypertension 2 and atherosclerosis. 27 Figure 4 demonstrates significant fluorescence staining in EGFP-transduced (control) p47phox ϩ/ϩ (A) and p47phox Ϫ/Ϫ (B) VSMCs and in p47phox-transduced p47phox ϩ/ϩ (C) and p47phox Ϫ/Ϫ (D) VSMCs. Microscopic inspections indicated that the efficiency of transduction by each virus was 90% to 100%. The extent of immunofluorescence staining in p47phox-transduced VSMCs indicated abundant expression of recombinant p47phox in these cells relative to untransduced cells ( Figure 3A and 3B) .
In the absence of stimulation, the amount of superoxide released by EGFP-transduced and p47phox-transduced cells †Significant differences (PϽ0.05; paired t tests) in mean superoxide production between nonstimulated condition and either agonist-stimulated condition.
was not significantly different ( Table 2 ). Under agoniststimulated conditions, superoxide production correlated with p47phox expression in p47phox-transduced p47phox Ϫ/Ϫ VSMCs in response to Ang II (10 nmol/L; Figure 5A and Table 2 ) or PDGF-BB (5 ng/mL; Figure 5B and Table 2 ). In contrast, EGFP-transduced p47phox Ϫ/Ϫ VSMCs did not produce superoxide after stimulation by either agonist ( Figure  5A and 5B and Table 2 ), indicating that retroviral transduction itself was insufficient to restore agonist-induced superoxide generation. Superoxide production yielded by p47phox-transduced p47phox Ϫ/Ϫ VSMCs in response to Ang II or PDGF-BB was comparable to that by EGFP-transduced p47phox ϩ/ϩ or p47phox-transduced p47phox ϩ/ϩ VSMCs (Figure 5A and 5B and Table 2 ). Furthermore, agonist-stimulated superoxide release by EGFP-transduced p47phox ϩ/ϩ and p47phox-transduced p47phox Ϫ/Ϫ and p47phox ϩ/ϩ VSMCs was significantly greater than that yielded under nonstimulated conditions. The levels of superoxide produced by VSMCs after stimulation by either agonist, however, were significantly lower than those yielded by PMA stimulation ( Table 1 , Ϸ3 weeks after harvest of aortas). Our data provide direct evidence that p47phox plays a role in superoxide production by VSMCs in response to physiological agonists.
Discussion
We provide genetic proof that p47phox participates in superoxide production in murine VSMCs. The selective ability of p47phox ϩ/ϩ VSMCs to produce superoxide was not attributed to phenotypic differences between p47phox ϩ/ϩ and p47phox Ϫ/Ϫ cultures, on the basis of indistinguishable ␣-smooth muscle actin staining patterns. Instead, superoxide production in p47phox ϩ/ϩ VSMCs was attributed to the exclusive expression of p47phox, because transduction of p47phox Ϫ/Ϫ VSMCs with recombinant human p47phox cDNA restored agonist-induced superoxide production. Ang II-or PDGF-stimulated superoxide production by EGFP-transduced p47phox ϩ/ϩ , p47phox-transduced p47phox Ϫ/Ϫ , and p47phox-transduced p47phox ϩ/ϩ VSMCs was significantly greater than that by nonstimulated cells.
Our results provide direct functional evidence that a phagocyte-like NADPH oxidase involving p47phox produces superoxide in VSMCs. In phagocytes, p47phox and other cytosolic proteins are essential cofactors of the enzyme, which do not themselves produce superoxide. 4 Previous demonstrations of p22phox-dependent 15 and Rac1dependent 28 superoxide production in VSMCs provide further evidence that a phagocyte-like oxidase functions in VSMCs. Interestingly, p22phox is reportedly not stabilized in the absence of gp91phox in phagocytes 29 ; gp91phox, however, was not detected in VSMCs. 11, 15 A homologue of gp91phox, such as Mox1, may act as the core electron transfer component of the VSMC oxidase. 11, 30 p67phox was not detected in VSMCs 13 but appears to participate in superoxide production in rabbit aortic adventitial fibroblasts. 10 The disparities in oxidase compositions between phagocytes and VSMCs may explain differences in their primary physiological roles and their distinct responses to different agonists. Indeed, superoxide release from VSMCs and phagocytes seems to have preferential roles in signal transduction 1 and host defense, 4 respectively. Further investigations are necessary to delineate the partners of p47phox that facilitate superoxide release by VSMCs or establish whether Mox1 could fulfil such a role.
In the blood vessel wall, a balance between the activities of enzymes that generate superoxide, 31 including those in the mitochondria, xanthine oxidase, cyclooxygenases, nitric oxide synthases, or NADPH oxidase (p22phox, 15 p47phox [this report and Reference 13], p67phox, 10 and gp91phox 11 ), and enzymes that scavenge superoxide or other ROS, 32 including SOD, catalase, and glutathione peroxidase, determines the extent of oxidative stress in tissues. By reacting with nitric oxide, superoxide abolishes the cardioprotective functions of this molecule, which can promote development of hypertension and atherosclerosis. 31 Thus, excess superoxide production, reductions in superoxide scavenger activity, or their combination can induce deleterious consequences in blood vessels.
The absolute level of superoxide liberated in the blood vessel wall may be determined by stimulation of the cellular components of this tissue. Ang II stimulated superoxide release from aortic adventitial fibroblasts in a dose-dependent manner, 10 and PDGF-AB stimulated dose-dependent superoxide production in human VSMCs. 20 In both cases, agoniststimulated superoxide production was greater than that produced under basal conditions. p47phox deficiency has no apparent effect on blood pressure or atherogenesis in the progeny of apoE Ϫ/Ϫ ϫp47phox Ϫ/Ϫ mice; however, the roles of Ang II and PDGF were not directly addressed. 33 The present results demonstrate that Ang II-or PDGF-stimulated, p47phox-dependent superoxide production by VSMCs was significantly greater than that produced under nonstimulated conditions. VSMC stimulation by these agonists may be necessary to induce ROS-mediated perturbations of cardiovascular function. In agreement with this notion, Ang II infusion concomitantly produced SOD-sensitive increases in blood pressure and aortic mRNA expression of p22phox in rats. 25 Laursen et al 26 showed that Ang II infusions, but not vehicle or norepinephrine infusions, in rats stimulated significant elevations in superoxide, which were accompanied by significant SOD-inhibitable increases in blood pressure. Furthermore, exposure of the canine basilar artery to graded increases in superoxide incrementally constricted this vessel in vitro. 34 Together, the studies described above suggest that agoniststimulated superoxide production may promote oxidative stress in vascular tissues, which appears to be involved in some types of hypertension 2 and in atherosclerosis. 35 As such, our findings demonstrate that Ang II or PDGF can stimulate a p47phox-dependent VSMC oxidase to generate significantly more superoxide than that produced under basal conditions. Future work should explore whether p47phox deficiency offers protection against hypertensive responses to chronic Ang II administration and whether the expression or activity of p47phox in VSMCs is responsive to inflammatory cytokines.
